Author pages are created from data sourced from our academic publisher partnerships and public sources.
Polymyalgia rheumatica and giant-cell arteritis.
- C. Salvarani, F. Cantini, L. Boiardi, G. Hunder
- The New England journal of medicine
- 1 August 1995
Summary The original descriptions of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) in the medical literature date back to 1888 and 1890, respectively. Classification criteria for PMR… Expand
2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative
- B. Dasgupta, M. Cimmino, +39 authors E. Matteson
- Annals of the rheumatic diseases
- 2 March 2012
The objective of this study was to develop EULAR/ACR classification criteria for polymyalgia rheumatica (PMR). Candidate criteria were evaluated in a 6-month prospective cohort study of 125 patients… Expand
Shoulder ultrasonography in the diagnosis of polymyalgia rheumatica: a case-control study.
OBJECTIVE Magnetic resonance imaging (MRI) showed that subacromial/subdeltoid bursitis is the most frequent shoulder lesion in polymyalgia rheumatica (PMR). We evaluated whether shoulder… Expand
Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice.
Since the introduction of biologics for the treatment of rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), and psoriasis (Pso) an increased risk of tuberculosis (TB)… Expand
Are polymyalgia rheumatica and giant cell arteritis the same disease?
- F. Cantini, L. Niccoli, +5 authors C. Salvarani
- Seminars in arthritis and rheumatism
- 1 April 2004
OBJECTIVE To summarize the evidence about the relationship between polymyalgia rheumatica (PMR) and giant cell arteritis (GCA). METHODS Review of relevant articles from the English-language… Expand
Treatment of longstanding active giant cell arteritis with infliximab: report of four cases.
2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.
The objective of this study was to develop European League Against Rheumatism/American College of Rheumatology classification criteria for polymyalgia rheumatica (PMR). Candidate criteria were… Expand
Isolated peripheral enthesitis and/or dactylitis: a subset of psoriatic arthritis.
OBJECTIVE To identify isolated peripheral enthesitis and/or dactylitis as a subset of psoriatic arthritis (PsA) and to define the clinical characteristics of these patients. METHODS We examined 401… Expand
The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy
Objective. To evaluate costs, benefits and cost–effectiveness of anti-TNF agents in PsA patients with inadequate response to conventional treatment. Methods. A total of 107 patients, from nine… Expand
Cervical interspinous bursitis in active polymyalgia rheumatica
- C. Salvarani, L. Barozzi, +9 authors G. Hunder
- Annals of the rheumatic diseases
- 21 January 2008
Objective: To evaluate the inflammatory involvement of cervical interspinous bursae in patients with polymyalgia rheumatica (PMR) using MRI. Methods: In all, 12 consecutive, untreated new patients… Expand